231 related articles for article (PubMed ID: 37161430)
1. Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer.
Liu Y; Li D; Chen Y; Liu Y; Lin Y; Huang X; Wu T; Wang C; Ding J
BMC Bioinformatics; 2023 May; 24(1):191. PubMed ID: 37161430
[TBL] [Abstract][Full Text] [Related]
2. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
3. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
Hu B; Meng Y; Qu C; Wang BY; Xiu DR
Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
[TBL] [Abstract][Full Text] [Related]
4. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
5. AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer.
Zeng Y; Zhang X; Li F; Wang Y; Wei M
J Clin Lab Anal; 2022 Jun; 36(6):e24437. PubMed ID: 35478418
[TBL] [Abstract][Full Text] [Related]
6. Development of cancer-associated fibroblasts subtype and prognostic model in gastric cancer and the landscape of tumor microenvironment.
Zhang C; Sun D; Li C; Liu Y; Zhou Y; Zhang J
Int J Biochem Cell Biol; 2022 Nov; 152():106309. PubMed ID: 36174922
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
Front Immunol; 2022; 13():977338. PubMed ID: 36159818
[TBL] [Abstract][Full Text] [Related]
8. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer.
Qiu F; Zhu Y; Shi Y; Ji J; Jin Y
Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261
[TBL] [Abstract][Full Text] [Related]
9. Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer.
Zeng C; He R; Dai Y; Lu X; Deng L; Zhu Q; Liu Y; Liu Q; Lu W; Wang Y; Jin J
Front Pharmacol; 2022; 13():1069204. PubMed ID: 36467074
[No Abstract] [Full Text] [Related]
10. Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer.
Qing X; Xu W; Liu S; Chen Z; Ye C; Zhang Y
Front Immunol; 2022; 13():843077. PubMed ID: 35273618
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis from multicentre studies identities m7G-related lncRNA-derived molecular subtypes and risk stratification systems for gastric cancer.
Ma M; Li J; Zeng Z; Zheng Z; Kang W
Front Immunol; 2023; 14():1096488. PubMed ID: 36936957
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis Based on the Cancer Immunotherapy and Immune Activation of Gastric Cancer Patients.
Jiang F; Ma Q
Genet Res (Camb); 2023; 2023():4674536. PubMed ID: 36923953
[TBL] [Abstract][Full Text] [Related]
14. TM-Score predicts immunotherapy efficacy and improves the performance of the machine learning prognostic model in gastric cancer.
Xiang K; Zhang M; Yang B; Liu X; Wang Y; Liu H; Song Y; Yuan Y; Zhang L; Wen T; Zhang GW
Int Immunopharmacol; 2024 Jun; 134():112224. PubMed ID: 38723370
[TBL] [Abstract][Full Text] [Related]
15. The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.
Xu X; Zhou N; Lan H; Yang F; Dong B; Zhang X
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077165
[TBL] [Abstract][Full Text] [Related]
16. A Novel Signature Based on m
Liu D; Li B; Yang M; Xing Y; Liu Y; Yuan M; Liu F; Wu Y; Ma X; Jia Y; Wang Y; Ji M; Zhu J
Adv Biol (Weinh); 2024 Apr; 8(4):e2300534. PubMed ID: 38314942
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics-based analysis of programmed cell death pathway and key prognostic genes in gastric cancer: Implications for the development of therapeutics.
Huang L; Xiong W; Cheng L; Li H
J Gene Med; 2024 Jan; 26(1):e3590. PubMed ID: 37670467
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
19. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
20. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer.
Liu SJ; Yang YB; Zhou JX; Lin YJ; Pan YL; Pan JH
Dis Markers; 2021; 2021():2385406. PubMed ID: 34868391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
